We are EU-GMP certified, one of the leading manufacturers of generic drugs in Vietnam. Established in 2004, certified in 2006 with WHO-GMP, in 2014 Davipharm reached first 100 registered products and started exporting its medicinal products to the Philippines and Cambodia. In 2017 Adamed Pharma S.A. acquired the controlling stake in Davipharm, marking the biggest direct Polish investment in Vietnam. In 2021 Davipharm opened the first certified HP Zone and got the EU-GMP certification. In 2023 Adamed Pharma bought the remaining shares at Davipharm, becoming a 100% shareholder of Davipharm. We focus on the technology transfer and manufacturing of the high-quality medicines in Vietnam for a domestic market and for export. Davipharm, a member of Adamed Group.
View Top Employees from Davipharm (Dat Vi Phu Pharmaceutical JSC)Website | http://www.davipharm.info |
Revenue | $2 million |
Employees | 124 (61 on RocketReach) |
Founded | 2004 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
SIC | SIC Code 335 Companies, SIC Code 33 Companies |
NAICS | NAICS Code 331 Companies, NAICS Code 3314 Companies, NAICS Code 33149 Companies, NAICS Code 33 Companies |
Looking for a particular Davipharm (Dat Vi Phu Pharmaceutical JSC) employee's phone or email?
The Davipharm (Dat Vi Phu Pharmaceutical JSC) annual revenue was $2 million in 2024.
61 people are employed at Davipharm (Dat Vi Phu Pharmaceutical JSC).
The NAICS codes for Davipharm (Dat Vi Phu Pharmaceutical JSC) are [331, 3314, 33149, 33].
The SIC codes for Davipharm (Dat Vi Phu Pharmaceutical JSC) are [335, 33].